A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially ...
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...
The FDA on Friday approved acellular tissue engineered vessel (Symvess), an off-the-shelf product for treating vascular ...
The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.
The Mechanobiology Lab explores how adherent cells can sense and respond to the mechanical stiffness of the extracellular matrix. The goal of the Vascular Engineering Lab is to develop novel ...
Silver Spring, Md Thursday, December 26, 2024, 11:00 Hrs [IST] ...
The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in ...
Atherosclerosis involves multiple processes including endothelial dysfunction, inflammation, vascular proliferation and matrix alteration. Vascular proliferation contributes to the pathobiology of ...
Hepatic fibrosis is a reversible wound healing response characterized by accumulation of extracellular matrix (ECM), or ... deposition of scar molecules, vascular and organ contraction, and ...
Aroa Biosurgery is targeting the growing lower-limb surgical salvage market with its Myriad family of products, which have ...